Webinar library

This webinar describes how a combination of analytically validated, high-throughput proteomics and transcriptomics can be used to identify prognostic ...

In this virtual roundtable discussion the leading experts share their opinions on how biomarkers can help drive early clinical phase ...

This free webinar will focus on exploring the power of proteomic discoveries, at the population scale in a breast cancer ...

Myocardial remodeling characterized by inflammation and fibrosis occurs prior to symptomatic hypertension (HTN). Moreover, patients with high blood pressure have ...

Using three independent COVID-19 patient cohorts and Olink® Explore 1536, Dr. Matsumoto collaborated with Massachusetts General Hospital to examine ...

Learn from a data scientist at Olink how to get the most out of your Olink® data. The following topics ...

Dr. Hu used the Olink® Explore platform to analyze proteins in the cerebrospinal fluid (CSF) of 315 HIV patients with ...

Dr. Galasko describes how Olink® PEA technology was employed to profile proteins related to mild cognitive impairment in HIV and ...

Multiple sclerosis (MS) is a chronic, heterogenous, progressive, and debilitating disease. The objective of Dr. Qureshi et al.’s research ...

Crohn’s disease (CD) is a heterogenous inflammatory bowel disease defined by a chronic inflammation of the gastrointestinal (GI) tract. ...

2947

Biomarker assays

~881 million

Protein data points generated

940

Publications listed on website

Contact us!